These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Meta-analysis of ACE inhibitor-induced angioedema identifies novel risk locus. Mathey CM, Maj C, Eriksson N, Krebs K, Westmeier J, David FS, Koromina M, Scheer AB, Szabo N, Wedi B, Wieczorek D, Amann PM, Löffler H, Koch L, Schöffl C, Dickel H, Ganjuur N, Hornung T, Buhl T, Greve J, Wurpts G, Aygören-Pürsün E, Steffens M, Herms S, Heilmann-Heimbach S, Hoffmann P, Schmidt B, Mavarani L, Andresen T, Sørensen SB, Andersen V, Vogel U, Landén M, Bulik CM, Estonian Biobank Research Team, DBDS Genomic Consortium, Bygum A, Magnusson PKE, von Buchwald C, Hallberg P, Rye Ostrowski S, Sørensen E, Pedersen OB, Ullum H, Erikstrup C, Bundgaard H, Milani L, Rasmussen ER, Wadelius M, Ghouse J, Sachs B, Nöthen MM, Forstner AJ. J Allergy Clin Immunol; 2024 Apr; 153(4):1073-1082. PubMed ID: 38300190 [Abstract] [Full Text] [Related]
4. Molecular Genetic Screening in Patients With ACE Inhibitor/Angiotensin Receptor Blocker-Induced Angioedema to Explore the Role of Hereditary Angioedema Genes. Mathey CM, Maj C, Scheer AB, Fazaal J, Wedi B, Wieczorek D, Amann PM, Löffler H, Koch L, Schöffl C, Dickel H, Ganjuur N, Hornung T, Forkel S, Greve J, Wurpts G, Hallberg P, Bygum A, Von Buchwald C, Karawajczyk M, Steffens M, Stingl J, Hoffmann P, Heilmann-Heimbach S, Mangold E, Ludwig KU, Rasmussen ER, Wadelius M, Sachs B, Nöthen MM, Forstner AJ. Front Genet; 2022 Apr; 13():914376. PubMed ID: 35923707 [Abstract] [Full Text] [Related]
10. Association of Variants Near the Bradykinin Receptor B2 Gene With Angioedema in Patients Taking ACE Inhibitors. Ghouse J, Ahlberg G, Andreasen L, Banasik K, Brunak S, Schwinn M, Larsen IH, Petersen O, Sørensen E, Ullum H, Rasmussen ER, Eriksson N, Hallberg P, Wadelius M, Bundgaard H, Olesen MS. J Am Coll Cardiol; 2021 Aug 17; 78(7):696-709. PubMed ID: 34384552 [Abstract] [Full Text] [Related]
13. Genetic susceptibility to angiotensin-converting enzyme-inhibitor induced angioedema: A systematic review and evaluation of methodological approaches. Ali HA, Lomholt AF, Mahmoudpour SH, Hermanrud T, Bygum A, von Buchwald C, Jakobsen MA, Rasmussen ER. PLoS One; 2019 Aug 17; 14(11):e0224858. PubMed ID: 31710633 [Abstract] [Full Text] [Related]
14. Antihypertensive drug associated angioedema: effect modification by race/ethnicity. Reichman ME, Wernecke M, Graham DJ, Liao J, Yap J, Chillarige Y, Southworth MR, Keeton S, Goulding MR, Mott K, Kelman JA. Pharmacoepidemiol Drug Saf; 2017 Oct 17; 26(10):1190-1196. PubMed ID: 28722207 [Abstract] [Full Text] [Related]
15. Comparative Risk of Angioedema With Sacubitril-Valsartan vs Renin-Angiotensin-Aldosterone Inhibitors. Eworuke E, Welch EC, Haug N, Horgan C, Lee HS, Zhao Y, Huang TY. J Am Coll Cardiol; 2023 Jan 31; 81(4):321-331. PubMed ID: 36697132 [Abstract] [Full Text] [Related]
19. Angioedema induced by angiotensin-converting enzyme inhibitors. Campo P, Fernandez TD, Canto G, Mayorga C. Curr Opin Allergy Clin Immunol; 2013 Aug 31; 13(4):337-44. PubMed ID: 23743513 [Abstract] [Full Text] [Related]
20. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea. Lee J, Lee S. Pharmacotherapy; 2018 Nov 31; 38(11):1095-1105. PubMed ID: 30225928 [Abstract] [Full Text] [Related] Page: [Next] [New Search]